FRIDAY, May 10, 2019 (HealthDay News) -- Endoscopic sleeve gastroplasty (ESG) is associated with significant total body weight loss (TBWL) over five years, according to a study presented at the 2019 Digestive Disease Week, held from May 18 to 21 in San Diego.
Kaveh Hajifathalian, M.D., M.P.H., from Cornell University in New York City, and colleagues examined the long-term efficacy of ESG for treating obesity in a retrospective review of 203 patients with obesity who underwent ESG between August 2013 and October 2018.
The researchers found that weight loss was 18.1 kg at one year, with a percentage TBWL of 15.2 percent. Weight loss was 17.3 kg at two years, with a percentage TBWL of 14.5 percent; at three and five years, weight loss was 20.8 and 18.7 kg, respectively, and percentage TBWL was 15.7 and 14.5 percent, respectively. The percentage of patients achieving ≥10 percent TBWL was 74, 67, 67, and 69, respectively, at 12, 24, 36, and 60 months. Patients were predicted to achieve their minimum weight at 24 months after ESG after fitting a quadratic regression; patients gained an average of 2.4 kg through the end of follow-up.
"We found very sustainable, significant weight loss for over 200 patients between the one- and five-year mark, losing an average of up to 15 to 20 percent of total body weight," a coauthor said in a statement.